RESEARCH TRIANGLE PARK, N.C. — Research Triangle Park-based biotechnology company Merakris Therapeutics has reached an agreement with Miracles In Sight (MIS) to supply Opticyte® Amniotic Ophthalmic Repair Grafts to MIS-affiliated eye surgeons in three states.Read More